Engling; Andre

Patent Applications and Registrations

Patent applications and USPTO patent grants for Engling; Andre.The latest application filed is for "uses of immunoconjugates targeting cd138".

Company Profile

1.11.8

Engling; Andre - Bad Homburg DE
Engling; Andre - Frankfurt am Main DE
Engling; Andre - Frankfurt N/A DE
Engling; Andre - Hamburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Uses Of Immunoconjugates Targeting Cd138 App 20190117770 - Schulz; Gregor ; et al.	2019-04-25
Uses of immunoconjugates targeting CD138 Grant 10,117,932 - Schulz , et al. November 6, 2	2018-11-06
Agents for treating disease Grant 9,995,733 - Osterroth , et al. June 12, 2	2018-06-12
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 9,605,066 - Osterroth , et al. March 28, 2	2017-03-28
Use of antibodies for detection of IL-10 Grant 9,540,436 - Osterroth , et al. January 10, 2	2017-01-10
Uses of immunoconjugates targeting CD138 Grant 9,289,509 - Osterroth , et al. March 22, 2	2016-03-22
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150218270 - OSTERROTH; Frank ; et al.	2015-08-06
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20150064179 - OSTERROTH; FRANK ; et al.	2015-03-05
Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,956,607 - Osterroth , et al. February 17, 2	2015-02-17
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) Grant 8,852,871 - Osterroth , et al. October 7, 2	2014-10-07
Uses Of Immunoconjugates Targeting Cd138 App 20140010828 - Schulz; Gregor ; et al.	2014-01-09
Agents For Treating Disease App 20130004513 - Osterroth; Frank ; et al.	2013-01-03
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321617 - Osterroth; Frank ; et al.	2012-12-20
Humanized Anti-il 10 Antibodies For The Treatment Of Systemic Lupus Erythematosus (sle) App 20120321618 - Osterroth; Frank ; et al.	2012-12-20
Uses Of Immunoconjugates Targeting Cd138 App 20110123554 - Osterroth; Frank ; et al.	2011-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.